Albany Molecular Research, Inc. Expands Manufacturing Capabilities in India; Adds Non-GMP Plant Capacity

ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI) today announced the expansion of multipurpose pilot plant facilities in Aurangabad, India providing non-GMP manufacturing services up to a 1,000 liter scale.
MORE ON THIS TOPIC